Back to search

Article

Distinct metabolic phenotype renders β-catenin mutant hepatocellular carcinoma susceptible to treatment-induced ischemia

2023-09-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background & Aims</h4> Transarterial chemoembolization (TACE) is the most common treatment for hepatocellular carcinoma (HCC) worldwide; however, response rates and durability vary widely. With the growing armamentarium of therapies for HCC patients, identifying predictors of response to TACE has become increasingly important for a patient population with limited hepatic reserve. We hypothesi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11cad0a9-44ad-5870-a41b-3af5d7e168e8
DOI
10.1101/2023.09.28.23296283
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinct metabolic phenotype renders β-catenin mutant hepatocellular carcinoma susceptible to treatment-induced ischemiaDOI 10.1101/2023.09.28.23296283
Select a neighboring publication to make it the new centre.